Therapeutic potential of targeting cathepsin S in pulmonary fibrosis.

Yoo, YoungJo; Choi, Eun; Kim, Yejin; Cha, Yunyoung; Um, Eunhye; Kim, Younghwa; Kim, Yunji; Lee, Yun-Sil

Yoo, YoungJo; Choi, Eun; Kim, Yejin; Cha, Yunyoung; Um, Eunhye; Kim, Younghwa; Kim, Yunji; Lee, Yun-Sil.

Affiliation

Yoo Y; Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 120-720, Republic of Korea.
Choi E; Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 120-720, Republic of Korea.
Kim Y; Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 120-720, Republic of Korea.
Cha Y; Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 120-720, Republic of Korea.
Um E; Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 120-720, Republic of Korea.
Kim Y; Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 120-720, Republic of Korea.
Kim Y; Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 120-720, Republic of Korea.
Lee YS; Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 120-720, Republic of Korea. Electronic address: yslee0425@ewha.ac.kr.

Biomed Pharmacother ; 145: 112245, 2022 Jan.

Article de En | MEDLINE | ID: mdl-34772578

Sujet(s)
Mots clés

Cathepsin S; Clinical and preclinical; Inhibitors; Pulmonary fibrosis; Therapeutic target

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fibrose pulmonaire / Cathepsines Limites: Animals / Humans Langue: En Journal: Biomed Pharmacother Année: 2022 Type de document: Article Pays de publication: France

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google